Enantioselective Synthesis of a (1R,5R,9R)-2-Azabicyclo[3.3.1]nonane-9-carboxylic Acid with an Embedded Morphan Motif: A Multipurpose Product

Narciso M. Garrido; Carlos T. Nieto; David Díez

doi:10.1055/s-0032-1317950

Synlett, Table of Contents

Synlett 2013; 24(2): 169-172
DOI: 10.1055/s-0032-1317950

letter

Enantioselective Synthesis of a (1R,5R,9R)-2-Azabicyclo[3.3.1]nonane-9-carboxylic Acid with an Embedded Morphan Motif: A Multipurpose Product

Narciso M. Garrido*

Departamento de Química Orgánica, Universidad de Salamanca, Plaza de los Caídos s/n, 37008 Salamanca, Spain Fax: +34(923)294574 Email: nmg@usal.es

,

Carlos T. Nieto

Departamento de Química Orgánica, Universidad de Salamanca, Plaza de los Caídos s/n, 37008 Salamanca, Spain Fax: +34(923)294574 Email: nmg@usal.es

,

David Díez

Departamento de Química Orgánica, Universidad de Salamanca, Plaza de los Caídos s/n, 37008 Salamanca, Spain Fax: +34(923)294574 Email: nmg@usal.es

› Author Affiliations

Abstract

All articles of this category

Abstract

A convenient asymmetric synthesis of (1R,5R,9R)-2-azabicyclo[3.3.1]nonane-9-carboxylic acid is described, starting from (2E,7E)-dimethyl nonadienedioate. The route involves a stereoselective domino Michael–Dieckman process that furnishes a 1,2,3-trisubstituted cyclohexane derivative bearing three adjacent stereocenters with full stereochemical control. A subsequent chemoselective transformation of one of the side-chain ester groups allows an effective second cyclization leading to the morphan motif. The versatility of this novel amino acid for the generation of molecular complexity was tested by elaborating a tripeptide in homogeneous phase.

Key words

β-amino acids - asymmetric synthesis - Michael addition - morphan - GABA uptake inhibitors

Full Text

References

References and Notes

1a Juaristi E, Soloshonok VA. Enantioselective Synthesis of β-Amino Acids . 2nd ed. John Wiley and Sons; Hoboken: 2005
1b Seebach D, Matthews JL. Chem. Commun. 1997; 21: 2015

2a Hanessian S, Auzzas L. Acc. Chem. Res. 2008; 41: 1241
2b Price JL, Horne WS, Gellman SH. J. Am. Chem. Soc. 2010; 132: 12378
2c Gellman SH. Acc. Chem. Res. 1998; 31: 173

3a Trost BM, Tang W, Toste FD. J. Am. Chem. Soc. 2005; 127: 14785
3b Gates M, Tschudi G. J. Am. Chem. Soc. 1952; 74: 1109
3c Toth JE, Fuchs PL. J. Org. Chem. 1987; 52: 473

4 Staub GM, Gloer JB, Wicklow DT, Dowd PF. J. Am. Chem. Soc. 1992; 114: 1015

5a Kong F, Andersen RJ, Allen TM. J. Am. Chem. Soc. 1994; 116: 6007
5b Proto S, Amat M, Pérez M, Ballette R, Romagnoli F, Mancinelli A, Bosch J. Org. Lett. 2012; 14: 3916

6 Fujii K, Sivonen K, Adachi K, Noguchi K, Shimizu Y, Sano H, Hirayama K, Suzuki M, Harada K.-I. Tetrahedron Lett. 1997; 38: 5529
7 Quirante J, Escolano C, Diaba F, Bonjoch J. Heterocycles 1999; 50: 731
8 Aurrecoechea JM, Gorgojo JM, Saornil C. J. Org. Chem. 2005; 70: 9640
9 Diaba F, Bonjoch J. Org. Biomol. Chem. 2009; 7: 2517

10a Garrido NM, Rubia AG, Nieto C, Díez D. Synlett 2010; 587
10b Garrido NM, Díez D, Domínguez SH, Sanchez MR, García M, Urones JG. Molecules 2006; 11: 435
10c Garrido NM, Díez D, Domínguez SH, García M, Sánchez MR, Davies SG. Tetrahedron: Asymmetry 2006; 17: 2183
10d Davies SG, Díez D, Domínguez SH, Garrido NM, Kruchinin D, Price PD, Smith AD. Org. Biomol. Chem. 2005; 3: 1284
10e Urones JG, Garrido NM, Díez D, El Hammoumi MM, Domínguez SH, Casaseca JA, Davies SG, Smith AD. Org. Biomol. Chem. 2004; 2: 364
10f Garrido NM, El Hammoumi MM, Díez D, García M, Urones JG. Molecules 2004; 9: 373
10g Urones JG, Garrido NM, Díez D, Domínguez SH, Davies SG. Tetrahedron: Asymmetry 1999; 10: 1637
10h Urones JG, Garrido NM, Díez D, Domínguez SH, Davies SG. Tetrahedron: Asymmetry 1997; 8: 2683

11 Scheffer JR, Wostradowski RA. J. Org. Chem. 1972; 37: 4317

12a Davies SG, Fletcher AM, Roberts PM, Thomson JE. Tetrahedron: Asymmetry 2012; 23: 1111

This review updates the scope and applications of the conjugate addition of enantiomerically pure lithium amides published in:

12b Davies SG, Smith AD, Price PD. Tetrahedron: Asymmetry 2005; 16, 2833

13 Nieto, C. T. PhD Dissertation, in progress.
14 The stereochemistry of this compound has been demonstrated in references 10d,g,c; the latter reports that (R)-6-methylcyclohex-1-ene carboxylate was obtained from an analogue of the enantiomer of 14.
15 Yoon NM, Chwang SP, Krishnamurthy S, Stocky TP, Brown HC. J. Org. Chem. 1973; 38: 2786
16 Barco A, Baricordi N, Benetti S, De Risi C, Pollinib GP, Zanirato V. Tetrahedron 2007; 63: 4278
17 Ella-Menye JR, Nie X, Wang G. Carbohydr. Res. 2008; 343: 1743
18 Typical Procedure Mesylate 18 (18 mg, 0.047 mmol) was dissolved in CH₂Cl₂–TFA 1:1 (5 mL) and stirred 2 h at r.t. Solvent was evaporated, and the crude was further dissolved in EtOH–Et₃N 1:1 (5 mL). The mixture was refluxed at 80 °C for 20 h. The solvent was again evaporated and the crude dissolved in EtOAc (30 mL) and extracted with HCl (0.5 M, 30 mL). The aqueous phase was basified to pH 8 with NaOH (1 M) and extracted with EtOAc. The organic phase was dried over Na₂SO₄, filtered, and the solvent was removed at reduced pressure. Purification of the crude product by flash chromatography (CHCl₃–MeOH, 9:1) provided 21 (7.1 mg, 84%) as an oil. [α]_D ²⁰ = –4.01 (c 0.71, CHCl₃). ¹H NMR (400 MHz, CDCl₃): δ = 1.65–2.24 (m, 8 H, H-4, H-6, H-7, H-8), 2.52 (s, 1 H, H-5), 3.06 (s, 1 H, H-9), 3.27 (dd, J = 13.5, 7.3 Hz, 1 H, H-3_eq), 3.44 (dt, J = 13.5, 8.0 Hz, 1 H, H-3_ax), 3.73 (s, 3 H, OCH₃), 3.91 (br s, 1 H, H-1), 5.51 (br s, 1 H, NH). IR (neat): 3396, 2931, 2858, 1733, 1426, 1384, 1287, 1203, 1124, 1405, 1023 cm^–1. ¹³C NMR (50 MHz, CDCl₃): δ = 19.8, 23.4, 25.5, 26.9, 28.9, 40.1, 43.6, 47.7, 52.7, 171.3. HRMS: m/z calcd for C₁₀H₁₈NO₂ [M + H]: 184.1332; found: 184.1313.
19 All the obtained products have been fully characterized including high-resolution mass spectrometry.
20 Kulig K, Szwaczkiewicz M. Mini-Rev. Med. Chem. 2008; 8: 1214